No abstract available
MeSH terms
-
Antimetabolites, Antineoplastic / pharmacology
-
Antimetabolites, Antineoplastic / therapeutic use
-
Azacitidine / pharmacology
-
Azacitidine / therapeutic use
-
Biomarkers
-
Biomarkers, Tumor
-
Bone Marrow / metabolism
-
Bone Marrow / pathology
-
Cell Transformation, Neoplastic / genetics
-
DNA Methylation / drug effects
-
Disease Progression
-
Down-Regulation
-
Gene Expression Regulation, Neoplastic* / drug effects
-
Humans
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / metabolism
-
Myelodysplastic Syndromes / drug therapy
-
Myelodysplastic Syndromes / genetics*
-
Myelodysplastic Syndromes / metabolism
-
Myelodysplastic Syndromes / physiopathology
-
Prognosis
-
Proto-Oncogene Proteins / biosynthesis*
-
Proto-Oncogene Proteins / genetics
-
Repressor Proteins / biosynthesis*
-
Repressor Proteins / genetics
-
Trans-Activators / biosynthesis*
-
Trans-Activators / genetics
-
Up-Regulation / drug effects
Substances
-
Antimetabolites, Antineoplastic
-
Biomarkers
-
Biomarkers, Tumor
-
JDP2 protein, human
-
Proto-Oncogene Proteins
-
Repressor Proteins
-
Trans-Activators
-
proto-oncogene protein Spi-1
-
Azacitidine